Richard Belle Isle, MD
Interventional Pain Medicine · Dalton, GANPI 1871790451
Payments from drug & device makers
What this record shows
Medtronic accounts for 63.7% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $2,084 and has fallen 90.5% since, to $198 in 2025.
Across 103 payments — averaging $52.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Stryker$626
- Boston Scientific$559
- Nevro Corp.$388
- Abbott$119
- Relievant Medsystems, Inc.$81
- plus $192 from 7 others
What the payments were for
- Travel & lodging$2,47346%
- Food & beverage$2,93354%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 47 | $3,442 |
| Stryker | 8 | $626 |
| Boston Scientific | 18 | $559 |
| Nevro Corp. | 13 | $388 |
| Abbott | 6 | $119 |
| Relievant Medsystems, Inc. | 3 | $81 |
| Saluda Medical Americas, Inc. | 2 | $69 |
| Curonix LLC | 1 | $27 |
| Si-bone, Inc. | 1 | $26 |
| Globus Medical | 1 | $25 |
| Biogen | 1 | $18 |
| Valinor Pharma, LLC | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KYPHON EXPRESS II KYPHOPAK TRAY$1,935
- SPINEJACK$449
- ADAPTIVESTIM$114
- WaveWriter Alpha Prime 16$106
- INTELLIS$105
- WAVEWRITER ALPHA$100
How this compares
$5,406 in reported general payments places this provider in the 55th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,573 | $34,702 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 650 | $21,913 |
| Fentanyl | 108 | $15,690 |
| Gabapentin | 821 | $10,094 |
| Oxycodone Hcl | 246 | $6,562 |
| Xtampza ErOxycodone Myristate | 11 | $5,429 |
| Tramadol Hcl ErTramadol Hcl | 86 | $4,720 |
| Morphine Sulfate | 86 | $3,613 |
| Pregabalin | 311 | $3,607 |
| Tizanidine Hcl | 438 | $3,517 |
| Morphine Sulfate ErMorphine Sulfate | 126 | $3,307 |
| Celecoxib | 86 | $2,659 |
| Tramadol Hcl | 349 | $2,558 |
| Cyclobenzaprine Hcl | 282 | $2,081 |
| Baclofen | 197 | $1,893 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Dalton
- Amit PatelDalton$7K
- Emmanuel GageBrunswick$602K
- Jordan TateJasper$540K
- Christopher BovinetBrunswick$338K
- David RosenfeldCovington$249K
- Nathan NeufeldNewnan$171K
- Ryan BudwanyLawrenceville$123K
- Alexandra MoreiraAtlanta$79K
- Sushanth BodaNewnan$55K
- Christopher AndrianoStockbridge$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.